Detalhe da pesquisa
1.
Phase II study of dual phosphoinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor BEZ235 in patients with locally advanced or metastatic transitional cell carcinoma.
BJU Int
; 118(3): 408-15, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26779597
2.
Long-lasting benefit on multimodal treatment combining osimertinib and stereotaxic radiotherapy for metastatic non-small cell lung cancer with the EGFR exon 20 insertion 773-774 HVdelinsLM: a case report.
Front Oncol
; 13: 1143775, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37465107
3.
Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.
J Geriatr Oncol
; 14(2): 101428, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36804333
4.
End-of-Life Care in the Last Three Months before Death in Older Patients with Cancer in Belgium: A Large Retrospective Cohort Study Using Data Linkage.
Cancers (Basel)
; 15(13)2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444458
5.
Long-term health-care utilisation in older patients with cancer and the association with the Geriatric 8 screening tool: a retrospective analysis using linked clinical and population-based data in Belgium.
Lancet Healthy Longev
; 4(7): e326-e336, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327806
6.
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
Clin Colorectal Cancer
; 20(4): 326-333, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34404621
7.
Unplanned hospitalizations in older patients with cancer: Occurrence and predictive factors.
J Geriatr Oncol
; 12(3): 368-374, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33223483
8.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Ann Oncol
; 26(4): 822-825, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814651
9.
Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use program.
J Geriatr Oncol
; 11(5): 796-801, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31791821
10.
The prognostic value of patient-reported Health-Related Quality of Life and Geriatric Assessment in predicting early death in 6769 older (≥70 years) patients with different cancer tumors.
J Geriatr Oncol
; 11(6): 926-936, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32305251
11.
Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis.
ESMO Open
; 5(5): e000947, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32978251
12.
Health related quality of life in older patients with solid tumors and prognostic factors for decline.
J Geriatr Oncol
; 10(6): 895-903, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31005649
13.
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?
Clin Genitourin Cancer
; 15(4): 502-508, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28258960
14.
Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program.
Urol Oncol
; 34(6): 254.e7-254.e13, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26850781
15.
Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer.
Target Oncol
; 10(3): 375-83, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25304881
16.
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.
J Clin Oncol
; 31(20): 2586-92, 2013 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23733761
17.
Open-label, phase II, multicenter, randomized study of the efficacy and safety of two dose levels of Pertuzumab, a human epidermal growth factor receptor 2 dimerization inhibitor, in patients with human epidermal growth factor receptor 2-negative metastatic breast cancer.
J Clin Oncol
; 28(7): 1131-7, 2010 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20124183
18.
Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative study.
Breast Cancer Res Treat
; 109(1): 59-65, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17592772